James Sapirstein - 15 Sep 2026 Form 4 Insider Report for Inmune Bio, Inc. (INMB)

Reporting relationship: Director
Issuer ticker: INMB
Reported as of: 15 Sep 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Sep 2026, 13:44:11 UTC
Prior SEC filing: 16 Sep 2026
Source filing: View source filing
Reporting owner signature: /s/ James Sapirstein

Key filing fact

James Sapirstein filed Form 4 for Inmune Bio, Inc. (INMB) on 17 Sep 2026.

Key facts

This page summarizes James Sapirstein's Form 4 filing for Inmune Bio, Inc. (INMB).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 17 Sep 2026, 13:44.

Change

Previous filing in this sequence was filed on 16 Sep 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001559509 Primary reporting owner

SAPIRSTEIN JAMES

Relationship: Director
Address: C/O INMUNE BIO INC., 225 NE MIZNER BLVD., SUITE 640, BOCA RATON
Signature: /s/ James Sapirstein
Signature date: 17 Sep 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INMB transaction Derivative

Stock Options

Award

Transaction value
Shares: +100,000
Change %
Price: $0.000000^*
Shares after: 100,000
Date: 15 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 100,000
Exercise price: $2.33
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represent an initial award of options in consideration for the Reporting Person's service to the Board of Directors of INmune Bio, Inc. Granted pursuant to the Issuer's Third Amended and Restated 2021 Stock Incentive Plan. The options will vest in 36 equal installments over three (3) years (1/36 per month) beginning one month after the grant date until the option is 100% vested which shall occur on the three-year anniversary of the date of grant.